Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mefloquine reduces the bacterial membrane fluidity of Acinetobacter baumannii and distorts the bacterial membrane when combined with polymyxin B

mBio(2025)10.1128/mbio.04016-24Source: DataRank Database

Mefloquine reduces the bacterial membrane fluidity of Acinetobacter baumannii and distorts the bacterial membrane when combined with polymyxin B is a research paper published in mBio (2025). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 2.22)OA: goldTopics (46)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Harikrishna Sekar Jayanthan,Jenna Port,Fernanda Cristina Possamai Rossatto ORCID,Eleftherios Mylonakis ORCID,Nagendran Tharmalingam ORCID

Live enrichment

PubMed:39998211 PMC:PMC11980597 OpenAlex:https://openalex.org/W4407913635

HHS | National Institutes of Health

Grant: P01 AI083214

National Institutes of Health

Grant: 5P01AI083214-10

Harvard-wide Program on Antibiotic Resistance

FWCI

2.22

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/mbio.04016-24

publisherhttps://doi.org/10.1128/mbio.04016-24

publisherhttps://journals.asm.org/doi/pdf/10.1128/mbio.04016-24

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39998211

repositoryhttps://doaj.org/article/5da59c88ee404c9d9eb6dfe41f8ecdbd

Fields of Study

Antibiotic Resistance in BacteriaBurkholderia infections and melioidosisMalaria Research and Control0301 basic medicine03 medical and health sciences

MeSH Terms

Acinetobacter InfectionsAnimalsAnti-Bacterial AgentsCell MembraneCell Membrane PermeabilityDrug SynergismMembrane FluidityMicrobial Sensitivity TestsPolymyxin BStructure-Activity RelationshipMefloquineAcinetobacter baumannii

Keywords

PolymyxinAcinetobacter baumanniiPolymyxin BLipid ABacterial outer membraneLipopolysaccharideMicrobiologyPseudomonas aeruginosaBiologyChemistryBacteriaBiochemistryEscherichia coliAntibioticsAntibiotic ResistancesynergyMefloquineA. BaumanniiCell Membrane PermeabilityMembrane FluidityCell MembraneDrug SynergismMicrobial Sensitivity TestsQR1-502Anti-Bacterial AgentsStructure-Activity RelationshipAnimalsResearch ArticleAcinetobacter Infections

Sustainable Development Goals

SDG 0: Good health and well-being